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ing Co. 1970), between 30 and 40% had
objective remissions.
Pre-treatment levels of prolactin were
variable, and were not changed by treatment,
whether or not remission occurred. Pre-
treatment levels of oestradiol varied less, but
were also substantially unchanged in all
patients during treatment. Growth hor-
mone showed no consistent response. In
most patients in whom regression of disease
was observed, values of luteinizing and
follicle stimulating hormone did not vary, but
in the majority ofnon-responders, gonadotro-
phin levels were lowered.
METABOLIC ABNORMALITIES IN
TUMOUR BEARING ANIMALS. K. C.
CALMAN and R. A. McALLISTER, Department
of Clinical Oncology, Western Infirmary,
Glasgow.
Twenty-four hours after implantation of
the TLX-5 lymphoma in CBA mice, the CoA
content of liver was significantly reduced
(P < 0-001). Significant reductions in the
CoA content continued up to the seventh day,
when the animals were in a moribund state.
The citrate content of liver showed no further
significant increases until the seventh day.
Significant reductions in energy content
(ATP, ADP, AMP) of these livers did not
occur until 6 days after implantation.
Control experiments in which normal CBA
mice were challenged with i.p. injections of
normal CBA spleen cells, or with spleen cells
from A strain mice, showed no change in the
CoA or citrate content of liver. No decrease
in CoA was noted in starvation experiments.
These results indicate that serious meta-
bolic abnormalities occur in the non-involved
organs of tumour bearing animals and these
may be related to the development of
cachexia.
UPTAKE OF 67GALLIUM BY NORMAL
LACTATING MAMMARY GLAND AND
BY TUMOURS IN THE DOG. A. T.
YOXALL and L. N. OWEN, Department of
Clinical Veterinary Medicine, University of
Cambridge.
Following intravenous injection of 67Ga
it is known that there is a concentration of
the isotope in several tumours and in a few
normal tumours, including lactating mam-
mary gland. Investigations in the lactating
bitch have shown that 67Ga and 45Ca were
taken up by the mammary tissue at the same
rate and that the isotopes reached similar
levels in both plasma and milk. The isotopes
were found to be associated with calcium
binding proteins in milk. It was not
possible to show any correlation between
67Ga and 45Ca uptake in a transmissible
venereal tumour.
A preliminary study to investigate ifthere
is any association between the " leakiness "
oftumour blood vessels as determined by the
uptake of 1251-albumin and 67Ga in a
melanoma has produced equivocal results.
THE PROGNOSIS FOLLOWING SUR-
GICAL EXCISION OF CANINE MAM-
MARY CARCINOMATA. D. E. Bos-
TOCK, Department of Clinical Veterinary
Medicine, University of Cambridge.
Spontaneously arising canine mammary
carcinomata may be of value as models in
immunotherapeutic trials for breast cancer in
women, but before their full potential can be
exploited their behaviour following surgery
alone must be known.
For this reason, 227 bitches from which
histologically confirmed mammary carcino-
mata had been excised were followed up.
Only 43% of these animals were eventually
destroyed as a result of the original tumour
but the accuracy of the prognosis could be
improved by histologically sub-dividing the
tumours. Papillary and tubular adeno-
carcinomata carried the most favourable
prognosis, the median survival times being 12
and 90 weeks. Dogs with solid carcinomata
had a medial post surgical survival time of44
weeks whereas for those with anaplastic
carcinoma it was only 11 weeks. Clinical
immunotherapeutic trials will thus be con-
centrated on dogs with the latter tumour
types.
Since most dogs die from their tumour
within 12 months of surgery it should be
possible to evaluate the effect ofpost surgical
immunotherapy sooner than would be
possible with a similar trial in man.
AUTORADIOGRAPHY OF EHRLICH
ASCITES TUMOURS TREATED WITH
SOYBEAN TRYPSIN INHIBITOR IN
VIVO. P. WHUR and H. KOPPEL, Cell
Biology Unit, Marie Curie Memorial Found-
ation, Oxted and B. WEATHERHEAD, Depart-248 B.A.C.R. 16TH ANNUAL GENLrRAL MEETING
ment of Anatomy, Birmingham University
Medical School.
We have previously reported (Whur et al.,
Br. J. Cancer, 1973, 28, 417) that intraperi-
toneal injections of soybean trypsin inhibitor
into tumour bearing mice reduced the number
of tumour cells recoverable in the ascitic
fluid by up to 92%, and tentatively proposed
on the basis of scanning E.M. observations
that this reduction was attributable to large
numbers of tumour cells adhering to the
peritoneum. We have traced the fate of
radiolabelled Ehrlich ascites tumour cells in
autoradiographs ofsections ofthe peritoneum
and of cells from the ascitic fluid from trypsin
inhibitor treated and untreated mice.
Our results indicate that cells on the
peritoneum of treated mice, previously
postulated to be tumour cells, are in fact of
host origin. The disappearance of tumour
cells from ascitic fluid of trypsin inhibitor
treated mice is probably attributable to an
enhanced inflammatory response in these
animals.
GROWTH OF A CANINE SOLID MAM-
MARY CARCINOMA IN VITRO AND
IN Nu MICE. L. N. OWEN and D. R.
MORGAN, Department of Clinical Veterinary
Medicine, University of Cambridge.
The biological behaviour of spontaneous
anaplastic or solid carcinoma ofthe mammary
gland in the dog is similar to carcinoma ofthe
breast in women.
A 14-year old cross-bred terrier bitch
developed rapidly growing and infiltrating
solid carcinomata in the pelvic mammary
glands on both sides. Following euthenasia,
metastatic tumours in the lungs were made
into a cell suspension and cultured in TC 199
containing 20% FCS. Better growth
occurred following transfer to RPMI medium
+ 30% FCS or a very complex medium
containing glutathione, cortisol and insulin.
The culture has now reached its 40th passage
with an approximate doubling time of5 days.
Cells from the 30th passage were injected
subcutaneously into a Nude mouse and within
22 days palpable tumours appeared. The
histological diagnosis was solid carcinoma of
similar appearance to the original primary
and metastatic tumours in the dog. Tumour
cells grown in tissue culture have been
injected into foetal dogs and newborn
puppies immunosuppressed with antilympho-
cyte serum.
GROWTH CHARACTERISTICS OF A
HUMAN BLADDER TUMOUR SUB-
CUTANEOUSLY IMPLANTED IN
IMMUNE DEFICIENT MICE. C. R.
FRANKS, Imperial Cancer Research Fund
Breast Unit, Guy's Hospital, London, D. R.
TURNER, Department of Pathology, Guy's
Hospital Medical School, London, and D.
BISHoP andF. T. PERKINS, National Institute
ofBiological Standards and Control, London.
In previous studies (Franks et al.,
Nature, Lond., 1973, 243, 91 andProc. R. Soc.
Med. (in press) 1974) it has been shown that
human tumours can be grown by sub-
cutaneous implantation in immune deficient
mice. Growth has been assessed by serial
measurements of the vertical and transverse
diameters of the palpable tumour, and
viability confirmed retrospectively at
autopsy.
In this study, a papillary cell carcinoma of
the human bladder on its second passage, 117
days after removal from the patient, was
subcutaneously implanted in 5 mice. During
the 70-day experimental period, needle
biopsy was performed under anaesthesia at
14-day intervals using a disposable Menghini
biopsy needle. The transverse and vertical
diameters of the tumours were also measured
using Vernier calipers.
The results show that between Day + 20
and Day + 25 there is a critical period
during which the implanted tumours appear
to undergo a process of selection, following
which there is either an active increase in
size or regression.
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FIBROBLASTS USING A PARTICLE
COUNTER COUPLED WITH A CHAN-
NEL ANALYSER. P. WHUR and H.
KOPPEL, Cell Biology Unit, Marie Curie
Memorial Foundation, Oxted.
We have examined cell aggregation in
shaking suspensions using a Coulter model Fn
counter coupled with a P64 channel analyser.
After calibration this apparatus is used to
detect the number of cells present in aggre-
gates up to a maximum size ofabout 50 cells,
and thus to calculate the net redistribution of
cells between aggregates as aggregation
progresses.